PTX 4.88% 3.9¢ prescient therapeutics limited

Ann: PTX-200 High Overall Response in Ph2a Breast Cancer trial, page-64

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 83 Posts.
    lightbulb Created with Sketch. 76
    Hi Eagleman, no you now have it correct. In your initial post you mentioned survival rate not pCR. I wanted to highlight they are two different things.
    They did indeed meet their criteria for this trial and blew it out of the water with ORR.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
3.9¢
Change
-0.002(4.88%)
Mkt cap ! $32.21M
Open High Low Value Volume
4.1¢ 4.2¢ 3.9¢ $35.46K 866.3K

Buyers (Bids)

No. Vol. Price($)
2 230290 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 79063 1
View Market Depth
Last trade - 15.45pm 01/10/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.